At the time of writing, Willis Towers Watson Public Limited Co [WTW] stock is trading at $337.00, down -0.28%. An important factor to consider is whether the stock is rising or falling in short-term value. The WTW shares have lost -0.28% over the last week, with a monthly amount drifted -0.99%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Willis Towers Watson Public Limited Co [NASDAQ: WTW] stock has seen the most recent analyst activity on March 18, 2025, when UBS upgraded its rating to a Buy and also boosted its price target to $395 from $344. Previously, Evercore ISI upgraded its rating to Outperform on January 08, 2025, and elevated its price target to $373. On December 20, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $382 on the stock. Raymond James upgraded its rating to a Strong Buy and increased its price target to $400 on December 05, 2024. Barclays initiated its recommendation with a Underweight and recommended $278 as its price target on September 05, 2024. BofA Securities upgraded its rating to Neutral for this stock on May 22, 2024, and upped its price target to $304. In a note dated February 12, 2024, Citigroup upgraded an Buy rating on this stock and boosted its target price from $236 to $315.
For the past year, the stock price of Willis Towers Watson Public Limited Co fluctuated between $245.04 and $344.14. Currently, Wall Street analysts expect the stock to reach $391 within the next 12 months. Willis Towers Watson Public Limited Co [NASDAQ: WTW] shares were valued at $337.00 at the most recent close of the market. An investor can expect a potential return of 16.02% based on the average WTW price forecast.
Analyzing the WTW fundamentals
According to Willis Towers Watson Public Limited Co [NASDAQ:WTW], the company’s sales were 9.93B for trailing twelve months, which represents an 4.15% jump. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 334.85 points at the first support level, and at 332.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 340.05, and for the 2nd resistance point, it is at 343.11.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 3.38, the price to book ratio is 4.24.
Transactions by insiders
Recent insider trading involved Gebauer Julie Jarecke, Pres.-Health, Wealth & Career, that happened on Mar 03 ’25 when 1616.0 shares were sold. Officer, Gebauer Julie Jarecke completed a deal on Mar 03 ’25 to buy 1616.0 shares. Meanwhile, Pres.-Health, Wealth & Career Gebauer Julie Jarecke sold 3384.0 shares on Feb 28 ’25.
